| scholarly article | Q13442814 |
| P356 | DOI | 10.1067/MAI.2000.109618 |
| P698 | PubMed publication ID | 11031334 |
| P2093 | author name string | Tilles SA | |
| Cook J | |||
| Nelson B | |||
| Holden WE | |||
| Priest J | |||
| Osborne ML | |||
| Sippel JM | |||
| O'Hollaren M | |||
| Thukkani N | |||
| P433 | issue | 4 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 645-650 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Exhaled nitric oxide levels correlate with measures of disease control in asthma | |
| P478 | volume | 106 |
| Q92826655 | Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management |
| Q37115894 | Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives. |
| Q47169950 | Asthma biomarkers in the age of biologics |
| Q43784447 | Asthma treatment with inhaled corticosteroids versus antileukotrienes: what exhaled nitric oxide studies do and do not tell us. |
| Q26782718 | Biomarkers and severe asthma: a critical appraisal |
| Q36582382 | Bronchial hyperresponsiveness to mannitol, airway inflammation and Asthma Control Test in atopic asthmatic children |
| Q37630008 | Clinical Utility of Fractional exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients |
| Q38134713 | Clinical utility of asthma biomarkers: from bench to bedside |
| Q37530846 | Comparison of orally exhaled nitric oxide in allergic versus nonallergic rhinitis |
| Q81828300 | Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide |
| Q38546516 | Does aspirin-induced oxidative stress cause asthma exacerbation? |
| Q42532738 | Does asthma control as assessed by the asthma control test reflect airway inflammation? |
| Q51498951 | Endothelial nitric oxide synthase gene polymorphisms are associated with sensitization to seasonal aeroallergens in asthmatic children. |
| Q26779074 | Exhaled NO: Determinants and Clinical Application in Children With Allergic Airway Disease |
| Q35907651 | Exhaled nitric oxide in the clinical management of asthma |
| Q37299822 | Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications |
| Q48014285 | Exhaled nitric oxide: relation to sensitization and respiratory symptoms |
| Q34106509 | Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values |
| Q34766276 | Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes |
| Q44680438 | Heterogeneity of FeNO response to inhaled steroid in asthmatic children |
| Q33931447 | Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study |
| Q36636416 | Is there a best outcome measurement for patients with asthma? |
| Q33926448 | Longitudinal assessment of high versus low levels of fractional exhaled nitric oxide among children with asthma and atopy |
| Q35536947 | Longitudinal study of grass pollen exposure, symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma |
| Q36198171 | Lung function and biomarkers of airway inflammation during and after hospitalization for acute exacerbations of childhood asthma associated with viral respiratory symptoms |
| Q24655820 | Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial |
| Q34874996 | Nitric oxide in respiratory diseases. |
| Q28073074 | Personalized Medicine in Allergy |
| Q44634868 | Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients |
| Q49201946 | Severe bronchial asthma in children: a review of novel biomarkers used as predictors of the disease |
| Q40724048 | Subjects in a Population Study with High Levels of FENO Have Associated Eosinophil Airway Inflammation |
| Q37114643 | The clinical significance of exhaled nitric oxide in asthma |
| Q80945174 | The clinical use of exhaled nitric oxide in wheezing children |
| Q37116793 | The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma |
| Q83410645 | [ALERTA 2 guidelines. Latin America and Spain: recommendations for the prevention and treatment of asmatic exacerbations. Spanish Pulmonology and Thoracic Surgery Society (SEPAR). Asthma Department of the Latinamerican Thoracic Association (ALAT)] |
| Q81179978 | [The measurement of exhaled nitric oxide, a new tool in the management of asthma?] |
Search more.